BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
Harvard Business School
Daiichi Sankyo
Boehringer Ingelheim
Federal Trade Commission
Farmers Insurance

Generated: December 15, 2017

DrugPatentWatch Database Preview

Claims for Patent: 3,674,836

« Back to Dashboard

Claims for Patent: 3,674,836

Abstract:A series of 2,2-dimethyl-.omega.-phenoxyalkanoic acids and 2,2-dimethyl-.omega.-(disubstituted phenoxy)alkanoic acids having 3 to 6 methylene groups between the phenoxy group or 0 phenoxy group and the carbon atom substituted by two methyl groups; and their salts and esters. The compounds reduce serum triglyceride levels and can be produced by (a) reacting an alkali metal derivative of an isobutyric acid, salt, or ester with a phenoxyalkyl halide or a disubstituted phenoxyalkyl halide; (b) esterifying a carboxylic acid; or (c) hydrolyzing a carboxylate ester.
Inventor(s): Creger; Paul L. (Ann Arbor, MI)
Assignee: Parke, Davis & Company (Detroit, MI)
Application Number:04/819,126
Patent Claims: 1. A compound of the formula ##SPC9##


n is 3, 4, 5, or 6;

R is a member of the class consisting of hydrogen, pharmaceutically-acceptable salt-forming cations, and lower alkyl; and Ar is a member of the class consisting of phenyl and groups of the formula ##SPC10##

in which R.sup.2 represents lower alkyl or halogen attached to the 2- or 3-position of the phenyl ring and R.sup.3 represents lower alkyl or halogen attached to the 5-position of the phenyl ring.

2. A compound according to claim 1 wherein R represents hydrogen.

3. A compound according to claim 1 wherein R represents lower alkyl.

4. A compound according to claim 1 which is 2,2-dimethyl-5-phenoxyvaleric acid.

5. A compound according to claim 1 which is 2,2-dimethyl-6-phenoxyhexanoic acid.

6. A compound according to claim 1 which is 2,2-dimethyl-5-(2,5-xylyloxy)valeric acid.

7. A compound according to claim 1 which is 2,2-dimethyl-5-(3,5-xylyloxy)valeric acid.
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Chinese Patent Office
US Army
Queensland Health
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch: